Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma

Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...

詳細記述

保存先:
書誌詳細
主要な著者: Marcos Oro-Ayude (著者), Hae Jin Suh-Oh (著者), Victor Sacristán-Santos (著者), Patricia Vázquez-Bartolomé (著者), Ángeles Flórez (著者)
フォーマット: 図書
出版事項: Karger Publishers, 2020-02-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料